KIR2DL2 Human Pre-designed siRNA Set A
KIR2DL2 Human Pre-designed siRNA Set A contains three designed siRNAs for KIR2DL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
For research use only. We do not sell to patients.
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
KIR2DL2 Human Pre-designed siRNA Set A contains three designed siRNAs for KIR2DL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Components
KIR2DL2 siRNA-1: 5 nmol (HPLC)
KIR2DL2 siRNA-2: 5 nmol (HPLC)
KIR2DL2 siRNA-3: 5 nmol (HPLC)
siRNA Negative Control: 5 nmol (HPLC)
FAM-labeled siRNA Negative Control: 5 nmol (HPLC)
GAPDH siRNA Positive Control: 5 nmol (HPLC)
Gene ID
Gene Information
KIR2DL2 - killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 2 Gene (Human)
Also Known as
NKAT6; p58.2; CD158b; NKAT-6; CD158B1
Chemical Information
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
RNA interference technology
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing gene transcription or activating RNA degradation. This mechanism was discovered in plants in 1998 by Andrew Fire and Craig Mello. Today, this phenomenon can be observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals.
Purity & Documentation
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)